Tag: Algovita
Nuvectra receives full-body MR-conditional CE Mark approval for Algovita
Nuvectra has announced that it has received full-body MR-conditional approval for the Company’s Algovita spinal cord stimulation (SCS) system from its European Notified Body,...
Nuvectra receives FDA head-only MR-conditional approval for Algovita
Nuvectra has announced that it has received US Food and Drug Administration (FDA) head-only MR-conditional approval for the company’s Algovita spinal cord stimulation (SCS) system.
Scott...
Algovita SCS System implantations reach 2,000 in the USA
Nuvectra Corporation, a neurostimulation medical device company, has announced that the Company’s Algovita Spinal Cord Stimulation (SCS) system has been implanted in over 2,000...
Soin Neuroscience commences a clinical case series with Nuvectra’s Algovita spinal...
Soin Neuroscience, a biotech company based in Dayton, Ohio, USA, has received IRB (institutional review board) approval to commence a clinical case series to study...
Low-profile multicolumn paddle lead improves access to spinal canal
A low-profile multicolumn paddle lead has provided an option for spinal cord stimulation therapy in an area which traditionally is difficult to access with...
Nuvectra picks up New Product Innovation Award for SCS device
Based on its recent analysis of the spinal cord stimulation (SCS) market, Frost & Sullivan has recognised Nuvectra with the 2017 North American New...
Nuvectra reports first quarter financial results
Nuvectra has announced the company’s financial results for the first quarter of 2016.
According to a press release, total revenue in the first quarter of...
